OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces that the Company will present a corporate overview at the 8th Annual Biotech Showcase Conference in San Francisco on Wednesday, 13 January 2016, at 9:30am PST in Room Mission II (4th Floor) at the Parc 55 San Francisco.
The presentation will be available on the Company’s website www.nordicnanovector.com following the event.
